Company intelligence / Profile preview

Sunstone Life Science Ventures Fund I

Copenhagen, Denmark

Ownership: Private
Development stage: Other

Overview

Sunstone Life Science Ventures Fund I is an early Sunstone investment vehicle focused on life science investments rather than operating as a drug-development company. The fund was established in 2007 with total committed capital of approximately EUR 200 million and invested across therapeutics, medical technology, and diagnostics. Public references identify the legal entity as Sunstone LSV Fund I K/S, including as a historical shareholder in portfolio company Nuevolution. The fund is no longer making new investments, but it appears to remain an existing legal fund vehicle under Sunstone's portfolio management structure rather than a closed operating biotech company.

Industry: Investors

Beyond the preview

Go deeper on Sunstone Life Science Ventures Fund I.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sunstone Life Science Ventures Fund I.

Explore the full profile